Featured Research

from universities, journals, and other organizations

New treatment for African sleeping sickness comes closer

Date:
November 5, 2013
Source:
Ume universitet
Summary:
Researchers have identified drugs targeting infections of the parasite Trypanosoma brucei and are thereby well on the way to find a cure against African sleeping sickness.

Researchers at Ume University have identified drugs targeting infections of the parasite Trypanosoma brucei and are thereby well on the way to find a cure against African sleeping sickness. This is the kernel of a thesis, which will be publicly defended on 8 November 2013.

African sleeping sickness (Human African trypanosomiasis) is caused by a parasite called Trypanosoma brucei. As the name of the disease indicates, it is associated with sleep disturbances but there are many other neurological complications as well. Unless the patient is treated, the illness develops in stages and leads eventually to unconsciousness and death. At present, there is no vaccine available and the medicines that exist are either very toxic or do not work effectively against all variants of the disease.

All cells have the potential to renew themselves infinitely through cell division. During cell division, the cell replicates its DNA, which constitutes the individual's genetic material, and then allows the DNA copy to pass on to the daughter cell. During this process, there is a need for a continuous supply of four different building blocks for DNA, i.e. dATP, dCTP, dTTP and dGTP. In human cells, these DNA building blocks can either be produced by the cells themselves, or absorbed in the form of so-called precursor molecules (deoxynucleosides) that are present in the blood and other body fluids.

It has already been observed that the parasite's production of RNA building blocks, which resemble DNA building blocks, could be a target for drug discovery whereas the parasite's production of DNA building blocks has not been studied to the same extent. Munender Vodnala from the Department of Medical Biochemistry and Biophysics has therefore focused his study on the cellular machinery involved in the production of DNA building blocks from precursor molecules. This is considered to be a promising target for drug development against the parasite.

The production of DNA building blocks from precursor molecules is made in three stages, so-called phosphorylations. Munender Vodnala has demonstrated that the enzyme adenosine kinase, which is involved in the first production stage, can be used by the parasite to produce dATP from the precursor molecule deoxyadenosine. When the parasite Trypanosoma brucei is cultivated in the presence of large amounts of deoxyadenosine, it produces high levels of dATP compared with mammalian cells. At these levels, dATP becomes toxic to the parasites and they die within just a few hours. Furthermore, Munender Vodnala has managed to identify two modified versions of deoxyadenosine, so-called analogues of deoxyadenosine. These resemble -- but are significantly more effective than -- deoxyadenosine itself in killing off the parasites.

"When we used deoxyadenosine analoues to treat mice that were infected with Trypanosoma brucei, we were able to cure the infections very successfully. These results indicate that we can now move on to develop an effective treatment for African sleeping sickness," explains Munender Vodnala.


Story Source:

The above story is based on materials provided by Ume universitet. Note: Materials may be edited for content and length.


Cite This Page:

Ume universitet. "New treatment for African sleeping sickness comes closer." ScienceDaily. ScienceDaily, 5 November 2013. <www.sciencedaily.com/releases/2013/11/131105194643.htm>.
Ume universitet. (2013, November 5). New treatment for African sleeping sickness comes closer. ScienceDaily. Retrieved August 23, 2014 from www.sciencedaily.com/releases/2013/11/131105194643.htm
Ume universitet. "New treatment for African sleeping sickness comes closer." ScienceDaily. www.sciencedaily.com/releases/2013/11/131105194643.htm (accessed August 23, 2014).

Share This




More Plants & Animals News

Saturday, August 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Endangered Red Wolves Face Uncertain Future

Endangered Red Wolves Face Uncertain Future

AP (Aug. 22, 2014) A federal judge temporarily banned coyote hunting to save endangered red wolves, but local hunters say that the wolf preservation program does more harm than good. Meanwhile federal officials are reviewing its wolf program in North Carolina. (Aug. 22) Video provided by AP
Powered by NewsLook.com
Farm Resurgence Grows With Younger Crowd

Farm Resurgence Grows With Younger Crowd

AP (Aug. 22, 2014) New England farms are seeing a surge in younger farm hands as the 'buy local' food movement grows across the country. (Aug. 22) Video provided by AP
Powered by NewsLook.com
Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Terrifying City-Dwelling Spiders Are Bigger And More Fertile

Terrifying City-Dwelling Spiders Are Bigger And More Fertile

Newsy (Aug. 21, 2014) According to a new study, spiders that live in cities are bigger, fatter and multiply faster. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins